Skip to main content


Page 5 of 300

  1. Mastocytosis is a very rare disorder and is divided into three prognostically distinct variants by World Health Organization: Cutaneous mastocytosis (CM), systemic mastocytosis (SM), and mast cell sarcoma or l...

    Authors: Tarık Onur Tiryaki, Sıdıka Gülkan Özkan, Simge Erdem, Aynur Dağlar Aday, İpek Yönal Hindilerden, Aslı Gelincik, Can Baykal, Gülçin Yegen, İbrahim Öner Doğan, Nesimi Büyükbabani, Meliha Nalçacı and Akif Selim Yavuz
    Citation: BMC Cancer 2023 23:82
  2. Childhood cancer (CC) is a leading cause of death among children aged 0–19 years worldwide. Each year, 400,000 new cases of CC are diagnosed globally. Given the between-country differences in CC incidence rate...

    Authors: Manushak Avagyan, Anahit Demirchyan and Lusine Abrahamyan
    Citation: BMC Cancer 2023 23:81
  3. Smoking is a modifiable risk factor for cancers. The aim of the study is to estimate the trend of mortality and DALYs of smoking-attributed cancers in the North Africa and Middle East (NAME) countries.

    Authors: Leila Rezakhani, Mitra Darbandi, Zahra Khorrami, Shima Rahmati and Fatemeh Khosravi Shadmani
    Citation: BMC Cancer 2023 23:80
  4. Cervical cancer is currently estimated to be the fourth most common cancer among women worldwide and the leading cause of cancer-related deaths in some of the world’s poorest countries. C/EBPβ has tumor suppre...

    Authors: Haichen Long, Yangyang Li, Huijuan Wang, Bingxuan Guo, Shuyan Song, Xiangyi Zhe, Hongtao Li, Dongmei Li, Renfu Shao and Zemin Pan
    Citation: BMC Cancer 2023 23:79
  5. Incidence and risk factors for seizures among women with advanced breast cancer (BC) and brain metastases are not well characterized across treatment-related or clinical subtypes. This study leveraged a large ...

    Authors: Alexander Liede, Wendy Sebby, Ashok Kumar Reddy Miriyala, Ravi Potluri, Debasish Mazumder, Anirban Ghosh, Eros Papademetriou, Ryan Kilpatrick and Jerzy E. Tyczynski
    Citation: BMC Cancer 2023 23:78
  6. Precision medicine with gene panel testing based on next-generation sequencing for patients with cancer is being used increasingly in clinical practice. HER2, which encodes the human epidermal growth factor recep...

    Authors: Yohei Harada, Akemi Sato, Hideaki Nakamura, Keita Kai, Sho Kitamura, Tomomi Nakamura, Yuki Kurihara, Sadakatsu Ikeda, Eisaburo Sueoka, Shinya Kimura and Naoko Sueoka-Aragane
    Citation: BMC Cancer 2023 23:77
  7. Gastric cancer peritoneal metastasis (GCPM) is an important cause of cancer-related deaths worldwide. Long non-coding RNAs (lncRNAs) play a key role in the regulation of GCPM, but the underlying mechanisms hav...

    Authors: Chao Dong, Fujuan Luan, Wenyan Tian, Kaipeng Duan, Tao Chen, Jiayu Ren, Weikang Li, Dongbao Li, Qiaoming Zhi and Jin Zhou
    Citation: BMC Cancer 2023 23:76
  8. Patients with follicular lymphoma (FL) can have high response rates to early lines of treatment. However, among FL patients relapsed/refractory (r/r) after ≥2 prior lines of therapy (LOT), remission tends to b...

    Authors: Steve Kanters, Graeme Ball, Brad Kahl, Adriana Wiesinger, Eve H. Limbrick-Oldfield, Akshay Sudhindra, Julia Thornton Snider and Anik R. Patel
    Citation: BMC Cancer 2023 23:74
  9. Stereotactic Body Radiation Therapy (SBRT) has been found beneficial for adrenal gland metastases (AGMs) with a high local control rate and low toxicity. The role of SBRT for AGMs in patients with liver cancer...

    Authors: Bichun Xu, Xianzhi Zhao, Di Chen, Wenjuan Zhao, Xiaoyan Wang, Changhua Ding, Zhiyong Yuan and Huojun Zhang
    Citation: BMC Cancer 2023 23:73
  10. “Anti-angiogenetic drugs plus chemotherapy” (anti-angio-chemo) and “immune checkpoint inhibitors plus chemotherapy” (ICI-chemo) are superior to traditional chemotherapy in the first-line treatment of patients ...

    Authors: Lan-Lan Pang, Jia-Di Gan, Yi-Hua Huang, Jun Liao, Wei-Tao Zhuang, Wael-Abdullah-Sultan Ali, Shao-Dong Hong, Li Zhang and Wen-Feng Fang
    Citation: BMC Cancer 2023 23:72
  11. Chronic infection with Kaposi’s sarcoma-associated herpes virus (KSHV) in B lymphocytes causes primary effusion lymphoma (PEL), the most aggressive form of KSHV-related cancer, which is resistant to convention...

    Authors: Tetsunori Sakamoto, Masahiko Ajiro, Akira Watanabe, Shingo Matsushima, Keiji Ueda and Masatoshi Hagiwara
    Citation: BMC Cancer 2023 23:71
  12. Authors: D. Doppenberg, M. G. Besselink, C. H. J. van Eijck, M. P. W. Intven, B. Groot Koerkamp, G. Kazemier, H. W. M. van Laarhoven, M. Meijerink, I. Q. Molenaar, J. J. M. E. Nuyttens, R. van Os, H. C. van Santvoort, G. van Tienhoven, H. M. Verkooijen, E. Versteijne, J. W. Wilmink…
    Citation: BMC Cancer 2023 23:70

    The original article was published in BMC Cancer 2022 22:1363

  13. The initial management of patients with sarcoma is a critical issue. We used the nationwide French National Cancer Institute-funded prospective sarcoma database NETSARC to report the management and oncologic outc...

    Authors: Pierre Kubicek, Axel Le Cesne, Cyril Lervat, Maud Toulmonde, Christine Chevreau, Florence Duffaud, Louis-Romée Le Nail, Magali Morelle, Nathalie Gaspar, Cécile Vérité, Marie-Pierre Castex, Nicolas Penel, Esma Saada, Sylvain Causeret, François Bertucci, Christophe Perrin…
    Citation: BMC Cancer 2023 23:69
  14. Nanoliposomal irinotecan plus fluorouracil/leucovorin (5-FU/LV) is a standard second-line therapy for patients with pancreatic cancer. Identification of biomarkers is important to determine appropriate treatme...

    Authors: Takeshi Kawakami, Akiko Todaka, Kotoe Oshima, Kunihiro Fushiki, Satoshi Hamauchi, Takahiro Tsushima, Tomoya Yokota, Yusuke Onozawa, Hirofumi Yasui and Kentaro Yamazaki
    Citation: BMC Cancer 2023 23:68
  15. Little is known about dementia’s impact on patterns of diagnosis, treatment, and outcomes in cancer patients. This study aimed to elucidate the differences in cancer staging, treatment, and mortality in older ...

    Authors: Toshitaka Morishima, Yoshihiro Kuwabara, Mari Kajiwara Saito, Satomi Odani, Haruka Kudo, Mizuki Kato, Kayo Nakata and Isao Miyashiro
    Citation: BMC Cancer 2023 23:67
  16. Historically, high hepatocellular carcinoma (HCC)–related mortality has been, in part, due to lack of effective therapies; however, several systemic therapies have been recently approved for HCC treatment, inc...

    Authors: Neehar D. Parikh, Allicia Girvan, Joshua Coulter, Jonathon Gable, Jiat Ling Poon, Sangmi Kim, Anindya Chatterjee and Marco Boeri
    Citation: BMC Cancer 2023 23:66
  17. Advances in multiple myeloma treatment and a proliferation of treatment options have resulted in improved survival rates and periods of symptom-free remission for many multiple myeloma patients. As a result, h...

    Authors: Carrie Dombeck, Teresa Swezey, Juan Marcos Gonzalez Sepulveda, Bryce B. Reeve, Thomas W. LeBlanc, David Chandler and Amy Corneli
    Citation: BMC Cancer 2023 23:65
  18. Peritoneal metastasis (PM) is not uncommon in patients with gastric cancer(GC), which affects clinical treatment decisions, but the relevant examination measures are not efficiently detected. Our goal was to d...

    Authors: Jia Yang, Hongtao Su, Tao Chen, Xinhua Chen, Hao Chen, Guoxin Li and Jiang Yu
    Citation: BMC Cancer 2023 23:64
  19. Duke pancreatic mono-clonal antigen type 2 (DUPAN-II) is a famous tumour maker for pancreatic cancer (PC) as well as carbohydrate antigen 19–9 (CA19-9). We evaluated the clinical implications of DUPAN-II level...

    Authors: Shinichiro Hasegawa, Hidenori Takahashi, Hirofumi Akita, Yosuke Mukai, Manabu Mikamori, Kei Asukai, Daisaku Yamada, Hiroshi Wada, Yoshiaki Fujii, Takahito Sugase, Masaaki Yamamoto, Tomohira Takeoka, Naoki Shinno, Hisashi Hara, Takashi Kanemura, Naotsugu Haraguchi…
    Citation: BMC Cancer 2023 23:63
  20. Indoleamine 2,3-dioxygenase 1 (IDO1) is an enzyme that converts tryptophan to kynurenine. IDO1 expression is found not only in tumor cells but also in immune cells and is associated with tumor proliferation an...

    Authors: Hiroaki Nozawa, Tetsuro Taira, Hirofumi Sonoda, Kazuhito Sasaki, Koji Murono, Shigenobu Emoto, Yuichiro Yokoyama, Yuzo Nagai, Shinya Abe and Soichiro Ishihara
    Citation: BMC Cancer 2023 23:62
  21. Preoperative assessment of lymphovascular invasion(LVI) of rectal cancer has very important clinical significance. However, accurate preoperative imaging evaluation of LVI is highly challenging because the res...

    Authors: Pengfei Tong, Danqi Sun, Guangqiang Chen, Jianming Ni and Yonggang Li
    Citation: BMC Cancer 2023 23:61
  22. Colorectal cancer is the third most diagnosed cancer globally and the second leading cause of cancer death. We examined colon and rectal cancer treatment patterns in Australia.

    Authors: Sarsha Yap, Emily He, Sam Egger, David E Goldsbury, Jie-Bin Lew, Preston J Ngo, Joachim Worthington, Hannah Rillstone, John R Zalcberg, Jeff Cuff, Robyn L Ward, Karen Canfell, Eleonora Feletto and Julia Steinberg
    Citation: BMC Cancer 2023 23:60
  23. Saroglitazar is a novel PPAR-α/γ agonist with predominant PPAR-α activity. In various preclinical models, saroglitazar has been shown to prevent & reverse symptoms of NASH. In view of these observations, and t...

    Authors: Suresh R. Giri, Bibhuti Bhoi, Chitrang Trivedi, Akshyaya Rath, Rohan Rathod, Anish Sharma, Ramchandra Ranvir, Shekhar Kadam, Kailash Ingale, Hiren Patel, Abraham Nyska and Mukul R. Jain
    Citation: BMC Cancer 2023 23:59
  24. CT is the major detection tool for pancreatic cancer (PC). However, approximately 40% of PCs < 2 cm are missed on CT, underscoring a pressing need for tools to supplement radiologist interpretation.

    Authors: Dawei Chang, Po-Ting Chen, Pochuan Wang, Tinghui Wu, Andre Yanchen Yeh, Po-Chang Lee, Yi-Hui Sung, Kao-Lang Liu, Ming-Shiang Wu, Dong Yang, Holger Roth, Wei-Chih Liao and Weichung Wang
    Citation: BMC Cancer 2023 23:58
  25. Circadian clock genes are significant in the occurrence and development of HCC and long-non coding RNAs (lncRNAs) are closely related to HCC progression. In this study, we aimed to establish a prognostic risk ...

    Authors: Zhen Zhang, Wenhui Gao, Xiaoning Tan, Tianhao Deng, Wanshuang Zhou, Huiying Jian and Puhua Zeng
    Citation: BMC Cancer 2023 23:57
  26. Computed tomography (CT) derived body composition measurements of sarcopenia are an emerging form of prognostication in many disease processes. Although the L3 vertebral level is commonly used to measure skel...

    Authors: Aisha A Arayne, Richard Gartrell, Jing Qiao, Paul N Baird and Justin MC Yeung
    Citation: BMC Cancer 2023 23:56
  27. Macrophage infiltration in the tumor microenvironment participates in the regulation of tumor progression. Previous studies have found that Notch signaling pathway is involved in regulating the progression of ...

    Authors: Kai Huang, Wenwu Luo, Jinmei Fang, Changjun Yu, Guangjie Liu, Xiaodong Yuan, Yun Liu and Wenyong Wu
    Citation: BMC Cancer 2023 23:55
  28. Ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles are of potential magnetic resonance imaging (MRI) contrast agents for tumor diagnosis. However, ultrasmall particle size or negative surface charge...

    Authors: Changyuan Wang, Yang Wang, Wangchuan Xiao, Xiaohua Chen, Renfu Li, Zhiyong Shen and Fengchun Lu
    Citation: BMC Cancer 2023 23:54
  29. The role of preoperative serum tumor markers in HAS patients was vague, we designed the study to explore the effect of preoperative serum tumor markers on predicting the prognosis of HAS patients.

    Authors: Xuesong Yang, Anqiang Wang, Jialin Li, Kai Zhou, Ke Ji, Xin Ji, Ji Zhang, Xiaojiang Wu and Zhaode Bu
    Citation: BMC Cancer 2023 23:53
  30. TGF-β-induced factor homeobox 2 (TGIF2) is a transcription regulator that is phosphorylated by EGFR/ERK signaling. However, the functions of phosphorylated (p)-TGIF2 in cancer are largely unknown. Here, we inv...

    Authors: Renle Du, Chen Wang, Jingjing Liu, Keyan Wang, Liping Dai and Wenzhi Shen
    Citation: BMC Cancer 2023 23:52
  31. Currently, the standard treatment for locally advanced cervical cancer is concurrent chemoradiation (CCRT). Forty percent of patients present with disease recurrence. This study aims to investigate the feasibi...

    Authors: Jing Li, Ya Li, Huafeng Wang, Lifei Shen, Qun Wang, Siqi Shao, Yuhong Shen, Haoping Xu, Hua Liu, Rong Cai and Weiwei Feng
    Citation: BMC Cancer 2023 23:51
  32. To investigate the predictive value of metabolic syndrome (MetS) and its components in biochemical recurrence (BCR) and adverse pathological features of patients with prostate cancer (PCa) after radical prosta...

    Authors: Zenan Liu, Xuehua Zhu, Jide He and Jian Lu
    Citation: BMC Cancer 2023 23:50
  33. With the advent of intensive combination regimens, an increasing number of patients with unresectable pancreatic cancer (UPC) have regained the opportunity for surgery. We investigated the clinical benefits an...

    Authors: Xiang Li, Xinyuan Liu, Na Lu, Yiwen Chen, Xiaochen Zhang, Chengxiang Guo, Wenbo Xiao, Xing Xue, Ke Sun, Meng Wang, Shunliang Gao, Yan Shen, Min Zhang, Jian Wu, Risheng Que, Jun Yu…
    Citation: BMC Cancer 2023 23:49
  34. Primary myelofibrosis [PMF] is a myeloproliferative neoplasm associated with reduced overall survival (OS). Management strategies for PMF have evolved over the last two decades, including approval of ruxolitin...

    Authors: Tsewang Tashi, Jingbo Yu, Shivani Pandya, Christopher Dieyi, Robyn Scherber and Shreekant Parasuraman
    Citation: BMC Cancer 2023 23:48
  35. New concepts for a more effective anti-cancer therapy are urgently needed. Experimental flaws represent a major counter player of this development and lead to inaccurate and unreproducible data as well as unsu...

    Authors: Senyao Shao, Lars Uwe Scholtz, Sarah Gendreizig, Laura Martínez-Ruiz, Javier Florido, Germaine Escames, Matthias Schürmann, Carsten Hain, Leonie Hose, Almut Mentz, Pascal Schmidt, Menghang Wang, Peter Goon, Michael Wehmeier, Frank Brasch, Jörn Kalinowski…
    Citation: BMC Cancer 2023 23:47
  36. Tumor microenvironment (TME) is of great importance to regulate the initiation and advance of cancer. The immune infiltration patterns of TME have been considered to impact the prognosis and immunotherapy sens...

    Authors: Yinghe Ding, Ling Chu, Qingtai Cao, Hanyu Lei, Xinyu Li and Quan Zhuang
    Citation: BMC Cancer 2023 23:45
  37. The vast majority of ovarian mucinous carcinomas are metastatic tumours derived from nonovarian primary cancers, typically gastrointestinal neoplasms. Therapy targeting claudin18.2 might be used in gastric, ga...

    Authors: Fujun Wang, Yao Yang, Xiuzhen Du, Xiaoying Zhu, Yanjiao Hu, Changyu Lu, Lei Sui, Han Zhao, Kejuan Song and Qin Yao
    Citation: BMC Cancer 2023 23:44
  38. Porphyromonas gingivalis plays an oncogenic role in development and progression of esophageal squamous cell carcinoma (ESCC). However, the impact of P. gingivalis on local recurrence of early ESCC or precancerous...

    Authors: She-Gan Gao, Zhi-Peng Qi, Yi-Jun Qi, Ying-Yong Hou, Yi-Wen Liu, Meng-Xiang Li, Bing Li, Di Sun, Qiang Shi, Shi-Lun Cai, Ping-Hong Zhou and Yun-Shi Zhong
    Citation: BMC Cancer 2023 23:43
  39. This study aimed to develop an integrated model for predicting the occurrence of postoperative seizures in patients with diffuse high-grade gliomas (DHGGs) using clinical and RNA-seq data.

    Authors: Lianwang Li, Chuanbao Zhang, Zheng Wang, Yinyan Wang, Yuhao Guo, Chong Qi, Gan You, Zhong Zhang, Xing Fan and Tao Jiang
    Citation: BMC Cancer 2023 23:42
  40. Due to inconsistency in neoadjuvant chemotherapy (NACT) response in advanced gastric cancer (GC), the indications remain the source of controversy. This study focused on identifying factors related to NACT che...

    Authors: Xian-Wen Liang, Wei-Sheng Xiao, Hao Lei, Qian-Cheng Huag, Yu-Lan Dong, Fang Wang and Wei-Peng Qing
    Citation: BMC Cancer 2023 23:41
  41. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Zheqiong Tan, Yaru Zou, Man Zhu, Zhenzhao Luo, Tangwei Wu, Chao Zheng, Aqing Xie, Hui Wang, Shiqiang Fang, Shuiyi Liu, Yong Li and Zhongxin Lu
    Citation: BMC Cancer 2023 23:40

    The original article was published in BMC Cancer 2021 21:409

  42. Colorectal cancer (CRC), ranking third in cancer prevalence and second in mortality worldwide, is mainly derived from colorectal adenoma (CRA). CRA is a common benign disease in the intestine with rapidly incr...

    Authors: Bangting Wang, Jiting Zhang, Xin Wang, Lili Zhao, Yan Wang, Zhining Fan, Li Liu and Wenqing Gao
    Citation: BMC Cancer 2023 23:39
  43. Gastrointestinal stromal tumor (GIST) is currently regarded as a potentially malignant tumor, and early diagnosis is the best way to improve its prognosis. Therefore, it will be meaningful to develop a new met...

    Authors: Lianhuang Li, Xingxin Huang, Shichao Zhang, Zhenlin Zhan, Deyong Kang, Guoxian Guan, Shuoyu Xu, Yongjian Zhou and Jianxin Chen
    Citation: BMC Cancer 2023 23:38
  44. As a first-line imaging modality, whole-body fluorine-18 fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) and 18F-FDG PET/magnetic resonance imaging (MRI) had been widel...

    Authors: Cici Zhang, Zhishan Liang, Wei Liu, Xuwen Zeng and Yuzhen Mo
    Citation: BMC Cancer 2023 23:37
  45. Cancer-related cognitive impairment (CRCI) is one of the most concerning conditions experienced by patients living with cancer and has a major impact on their quality of life. Available cognitive assessment to...

    Authors: Amel Baghdadli, Giovanni G. Arcuri, Clarence G. Green, Lynn R. Gauthier, Pierre Gagnon and Bruno Gagnon
    Citation: BMC Cancer 2023 23:35
  46. Diminished immune defense plays an important role in cancer development. Cancer risk in immunocompromised patients may differ. Identifying individuals with elevated cancer risk can inform strategies for routin...

    Authors: Sabrina Ilham, Connor Willis, Kibum Kim, Karen C. Chung, Brenda M. Wood, Malinda S. Tan, Chia Jie Tan, Danielle T. Nguyen, Diana I. Brixner and David D. Stenehjem
    Citation: BMC Cancer 2023 23:33
  47. The link between immediate hypersensitivity reactions (HSR) following the first cetuximab infusion and the IgE sensitization against anti-galactose-α-1,3-galactose (α-Gal) is now well-established. An automated...

    Authors: Julien Serrier, Jean-Baptiste Davy, Benoît Dupont, Bénédicte Clarisse, Jean-Jacques Parienti, Gautier Petit, Kathy Khoy, Yann Ollivier, Radj Gervais, Delphine Mariotte and Brigitte Le Mauff
    Citation: BMC Cancer 2023 23:32
  48. To compare recurrence and survival in patients with stage III endometrial cancer after radical surgery, followed by either adjuvant chemoradiotherapy (ACR) or adjuvant chemotherapy (AC).

    Authors: Si-yu Cao, Yu Fan, Yu-fei Zhang, Jia-ying Ruan, Yi Mu and Jin-ke Li
    Citation: BMC Cancer 2023 23:31

Featured videos

View featured videos from across the BMC-series journals